会員登録
ログイン
【4886】あすか製薬ホールディングス
医薬品、医薬部外品、食品、動物用医薬品、飼料および飼料添加物、医療機器 等の製造・販売ならびに輸出入、臨床検査・試験業務等を営む子会社等の経営 管理およびこれに附帯する業務
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2024/11/05 | Q2予 | 63,000 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% | 5,000 | → | 0.0% | 0.0% |
| 2025.03 | 2024/08/05 | Q1予 | 63,000 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% | 6,700 | → | 0.0% | 0.0% | 5,000 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/10 | 当初予 | 63,000 | - | - | - | 6,700 | - | - | - | 6,700 | - | - | - | 5,000 | - | - | - |
| 2024.03 | 2024/05/10 | 実 | 62,843 | ↑ | +1.4% | +1.4% | 6,500 | ↑ | +20.4% | +20.4% | 6,522 | ↑ | +18.6% | +18.6% | 7,545 | ↑ | +21.7% | +71.5% |
| 2024.03 | 2024/02/05 | Q3予 | 62,000 | → | 0.0% | 0.0% | 5,400 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% | 6,200 | → | 0.0% | +40.9% |
| 2024.03 | 2023/11/06 | Q2予 | 62,000 | → | 0.0% | 0.0% | 5,400 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% | 6,200 | ↑ | +40.9% | +40.9% |
| 2024.03 | 2023/08/07 | Q1予 | 62,000 | → | 0.0% | 0.0% | 5,400 | → | 0.0% | 0.0% | 5,500 | → | 0.0% | 0.0% | 4,400 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/11 | 当初予 | 62,000 | - | - | - | 5,400 | - | - | - | 5,500 | - | - | - | 4,400 | - | - | - |
| 2023.03 | 2023/05/11 | 実 | 60,461 | ↑ | +0.8% | +5.1% | 5,108 | ↓ | -1.8% | +21.6% | 5,232 | ↓ | -1.3% | +21.7% | 4,238 | ↑ | +0.9% | +28.4% |
| 2023.03 | 2023/02/06 | Q3予 | 60,000 | → | 0.0% | +4.3% | 5,200 | → | 0.0% | +23.8% | 5,300 | → | 0.0% | +23.3% | 4,200 | → | 0.0% | +27.3% |
| 2023.03 | 2022/11/07 | Q2予 | 60,000 | ↑ | +4.3% | +4.3% | 5,200 | ↑ | +23.8% | +23.8% | 5,300 | ↑ | +23.3% | +23.3% | 4,200 | ↑ | +27.3% | +27.3% |
| 2023.03 | 2022/08/08 | Q1予 | 57,500 | → | 0.0% | 0.0% | 4,200 | → | 0.0% | 0.0% | 4,300 | → | 0.0% | 0.0% | 3,300 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/12 | 当初予 | 57,500 | - | - | - | 4,200 | - | - | - | 4,300 | - | - | - | 3,300 | - | - | - |
| 2022.03 | 2022/05/12 | 実 | 56,607 | ↓ | -0.7% | +8.9% | 4,795 | ↑ | +6.6% | +219.7% | 4,880 | ↑ | +8.4% | +225.3% | 4,290 | ↑ | +43.0% | +436.3% |
| 2022.03 | 2022/03/28 | 修正予 | 57,000 | ↑ | +3.6% | +9.6% | 4,500 | ↑ | +28.6% | +200.0% | 4,500 | ↑ | +25.0% | +200.0% | - | - | - | - |
| 2022.03 | 2022/02/07 | Q3予 | 55,000 | → | 0.0% | +5.8% | 3,500 | → | 0.0% | +133.3% | 3,600 | ↑ | +2.9% | +140.0% | 3,000 | ↑ | +215.4% | +275.0% |
| 2022.03 | 2021/12/20 | 修正予 | 55,000 | ↑ | +0.9% | +5.8% | 3,500 | → | 0.0% | +133.3% | 3,500 | ↓ | -2.8% | +133.3% | - | - | - | - |
| 2022.03 | 2021/11/01 | Q2予 | 54,500 | → | 0.0% | +4.8% | 3,500 | → | 0.0% | +133.3% | 3,600 | ↑ | +2.9% | +140.0% | -2,600 | ↓ | -425.0% | -425.0% |
| 2022.03 | 2021/09/27 | 修正予 | 54,500 | ↑ | +4.8% | +4.8% | 3,500 | ↑ | +133.3% | +133.3% | 3,500 | ↑ | +133.3% | +133.3% | - | - | - | - |
| 2022.03 | 2021/08/02 | 当初予 | 52,000 | - | - | - | 1,500 | - | - | - | 1,500 | - | - | - | 800 | - | - | - |
